INSP vs. BMY
INSP (Inspire Medical Systems, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. Both are in the Healthcare sector — INSP in Medical Devices, BMY in Drug Manufacturers - General. Over the past 5 years, INSP returned -22.80%/yr vs 3.38%/yr for BMY. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
INSP vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INSP achieves a -45.56% return, which is significantly lower than BMY's 25.17% return.
INSP
- 1D
- 0.38%
- 1M
- 6.94%
- 6M
- -33.74%
- YTD
- -45.56%
- 1Y
- -60.18%
- 3Y*
- -44.32%
- 5Y*
- -22.80%
- 10Y*
- —
- ALL TIME*
- 9.10%
BMY
- 1D
- 0.69%
- 1M
- 12.35%
- 6M
- 21.21%
- YTD
- 25.17%
- 1Y
- 54.75%
- 3Y*
- 6.92%
- 5Y*
- 3.38%
- 10Y*
- 2.16%
- ALL TIME*
- 9.43%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $711.50M | $665.03M | $681.59M | |
| $40.00M | $44.43M | $52.50M |
INSP vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
INSP Inspire Medical Systems, Inc. | -45.56% | -50.25% | -8.87% | -19.24% | 9.48% | 22.31% | 153.46% | 75.64% | 72.52% |
BMY Bristol-Myers Squibb Company | 25.17% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | 2.32% |
Correlation
The correlation between INSP and BMY is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since May 3, 2018 | 0.17 |
Fundamentals
INSP:
$1.45B
BMY:
$133.37B
INSP:
$4.50
BMY:
$4.54
INSP:
11.17
BMY:
14.37
INSP:
0.06
BMY:
0.82
INSP:
1.60
BMY:
2.71
INSP:
1.82
BMY:
5.99
INSP:
$915.25M
BMY:
$49.19B
INSP:
$785.06M
BMY:
$34.51B
INSP:
$67.14M
BMY:
$16.67B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INSP vs. BMY — Risk / Return Rank
INSP
BMY
INSP vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INSP | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.94 | ||
| Sortino ratioReturn per unit of downside risk | -4.15 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.36 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.83 | 4.66 | -5.48 |
| Martin ratioReturn relative to average drawdown | -1.17 | 11.09 | -12.26 |
Loading charts...
Drawdowns
INSP vs. BMY - Drawdown Comparison
The maximum INSP drawdown since its inception was -87.72%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for INSP and BMY.
Loading charts...
Drawdown Indicators
| INSP | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.72% | -72.03% | -15.69% |
Max Drawdown (1Y)Largest decline over 1 year | -72.19% | -12.53% | -59.66% |
Max Drawdown (3Y)Largest decline over 3 years | -85.55% | -34.11% | -51.44% |
Max Drawdown (5Y)Largest decline over 5 years | -87.72% | -47.67% | -40.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -47.67% | — |
Current DrawdownCurrent decline from peak | -84.60% | -4.95% | -79.65% |
Average DrawdownAverage peak-to-trough decline | -28.68% | -22.36% | -6.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.14% | 5.25% | +45.89% |
Volatility
INSP vs. BMY - Volatility Comparison
Inspire Medical Systems, Inc. (INSP) has a higher volatility of 13.40% compared to Bristol-Myers Squibb Company (BMY) at 9.10%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INSP | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.40% | 9.10% | +4.30% |
Volatility (6M)Calculated over the trailing 6-month period | 39.42% | 19.64% | +19.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.49% | 27.86% | +47.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.26% | 24.49% | +35.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.30% | 25.46% | +34.84% |
Dividends
INSP vs. BMY - Dividend Comparison
INSP has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 3.84%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 3.84% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
INSP Inspire Medical Systems, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
INSP vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INSP vs. BMY - Profitability Comparison
INSP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported a gross profit of 176.91M and revenue of 204.58M. Therefore, the gross margin over that period was 86.5%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a gross profit of 9.25B and revenue of 12.97B. Therefore, the gross margin over that period was 71.3%.
INSP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported an operating income of -1.12M and revenue of 204.58M, resulting in an operating margin of -0.6%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported an operating income of 4.09B and revenue of 12.97B, resulting in an operating margin of 31.5%.
INSP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported a net income of -11.29M and revenue of 204.58M, resulting in a net margin of -5.5%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bristol-Myers Squibb Company reported a net income of 3.32B and revenue of 12.97B, resulting in a net margin of 25.6%.
Frequently Asked Questions
INSP and BMY have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INSP has higher volatility (13.40%) compared to BMY (9.10%). In terms of maximum drawdown, INSP dropped -87.72% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (2.14 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INSP and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer